MARKET

DVHGF

DVHGF

DEVONIAN HEALTH GROUP INC
OTCMQB
5.78
-0.72
-11.08%
Closed 15:49 09/10 EDT
OPEN
5.78
PREV CLOSE
6.50
HIGH
5.78
LOW
5.78
VOLUME
100
TURNOVER
578
52 WEEK HIGH
10.65
52 WEEK LOW
4.266
MARKET CAP
15.99M
P/E (TTM)
-3.1115
1D
5D
1M
3M
1Y
5Y
1D
Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay
PR Newswire · 09/01 12:45
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Moderate Atopic Dermatitis in Patients Aged 3 Months to 17 Years
PR Newswire · 07/21 12:45
Devonian Health Group GAAP EPS of -$0.81
Seeking Alpha · 03/26 18:58
DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING
PR Newswire · 01/20 14:00
Devonian Health Group Announces Grant of Stock Options
Barchart · 12/19/2025 08:15
Weekly Report: what happened at DVHGF last week (0908-0912)?
Weekly Report · 09/15/2025 09:40
About DVHGF
Devonian Health Group Inc. is a clinical stage pharmaceutical company specializing in the development of drugs for various autoimmune fibroinflammatory diseases with novel therapeutic approaches to targeting unmet medical needs. The Company is to develop prescription drugs for the treatment of fibroinflammatory autoimmune diseases including but not limited to atopic dermatitis, radiodermatitis and ulcerative colitis. It is also involved in the development of cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its Thykamine is an active lead drug candidate with safety and profiles confirmed in several pre-clinical and clinical studies targeting inflammation. Its cosmeceutical products include R-Spinasome and Purgenesis. The Company’s subsidiary, Altius Healthcare LP, focused on selling prescription pharmaceutical products in Canada, under licenses from brand-name pharmaceutical companies.

Webull offers Devonian Health Group Inc stock information, including OTCMQB: DVHGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DVHGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DVHGF stock methods without spending real money on the virtual paper trading platform.